Literature DB >> 26962230

TRIM21 Immune Signaling Is More Sensitive to Antibody Affinity Than Its Neutralization Activity.

Stian Foss1,2, Ruth E Watkinson3, Algirdas Grevys1,2, Martin B McAdam2, Malin Bern1,2, Lene Stokken Høydahl1,2, Bjørn Dalhus4, Terje E Michaelsen5,6, Inger Sandlie1,2, Leo C James3, Jan Terje Andersen1,2.   

Abstract

Ab-coated viruses can be detected in the cytosol by the FcR tripartite motif-containing 21 (TRIM21), which rapidly recruits the proteasomal machinery and triggers induction of immune signaling. As such, TRIM21 plays a key role in intracellular protection by targeting invading viruses for destruction and alerting the immune system. A hallmark of immunity is elicitation of a balanced response that is proportionate to the threat, to avoid unnecessary inflammation. In this article, we show how Ab affinity modulates TRIM21 immune function. We constructed a humanized monoclonal IgG1 against human adenovirus type 5 (AdV5) and a panel of Fc-engineered variants with a wide range of affinities for TRIM21. We found that IgG1-coated viral particles were neutralized via TRIM21, even when affinity was reduced by as much as 100-fold. In contrast, induction of NF-κB signaling was more sensitive to reduced affinity between TRIM21 and the Ab variants. Thus, TRIM21 mediates neutralization under suboptimal conditions, whereas induction of immune signaling is balanced according to the functional affinity for the incoming immune stimuli. Our findings have implications for engineering of antiviral IgG therapeutics with tailored effector functions.
Copyright © 2016 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26962230      PMCID: PMC4977002          DOI: 10.4049/jimmunol.1502601

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  27 in total

1.  Versatile vectors for transient and stable expression of recombinant antibody molecules in mammalian cells.

Authors:  L Norderhaug; T Olafsen; T E Michaelsen; I Sandlie
Journal:  J Immunol Methods       Date:  1997-05-12       Impact factor: 2.303

Review 2.  The NF-kappa B and I kappa B proteins: new discoveries and insights.

Authors:  A S Baldwin
Journal:  Annu Rev Immunol       Date:  1996       Impact factor: 28.527

3.  Adenovirus-mediated expression of green fluorescent protein.

Authors:  R de Martin; M Raidl; E Hofer; B R Binder
Journal:  Gene Ther       Date:  1997-05       Impact factor: 5.250

4.  Effector function activities of a panel of mutants of a broadly neutralizing antibody against human immunodeficiency virus type 1.

Authors:  M Hezareh; A J Hessell; R C Jensen; J G van de Winkel; P W Parren
Journal:  J Virol       Date:  2001-12       Impact factor: 5.103

5.  Postentry neutralization of adenovirus type 5 by an antihexon antibody.

Authors:  Robin Varghese; Yeshi Mikyas; Phoebe L Stewart; Robert Ralston
Journal:  J Virol       Date:  2004-11       Impact factor: 5.103

6.  Structural insights into neonatal Fc receptor-based recycling mechanisms.

Authors:  Vaheh Oganesyan; Melissa M Damschroder; Kimberly E Cook; Qing Li; Changshou Gao; Herren Wu; William F Dall'Acqua
Journal:  J Biol Chem       Date:  2014-01-27       Impact factor: 5.157

7.  TRIM21 is an IgG receptor that is structurally, thermodynamically, and kinetically conserved.

Authors:  Anthony H Keeble; Zahra Khan; Alan Forster; Leo C James
Journal:  Proc Natl Acad Sci U S A       Date:  2008-04-17       Impact factor: 11.205

8.  Crystal structure of the HSV-1 Fc receptor bound to Fc reveals a mechanism for antibody bipolar bridging.

Authors:  Elizabeth R Sprague; Chu Wang; David Baker; Pamela J Bjorkman
Journal:  PLoS Biol       Date:  2006-05-02       Impact factor: 8.029

9.  Sequential ubiquitination and deubiquitination enzymes synchronize the dual sensor and effector functions of TRIM21.

Authors:  Adam J Fletcher; Donna L Mallery; Ruth E Watkinson; Claire F Dickson; Leo C James
Journal:  Proc Natl Acad Sci U S A       Date:  2015-07-06       Impact factor: 11.205

10.  TRIM21 Promotes cGAS and RIG-I Sensing of Viral Genomes during Infection by Antibody-Opsonized Virus.

Authors:  Ruth E Watkinson; William A McEwan; Jerry C H Tam; Marina Vaysburd; Leo C James
Journal:  PLoS Pathog       Date:  2015-10-27       Impact factor: 6.823

View more
  16 in total

Review 1.  Vaccinal antibodies: Fc antibody engineering to improve the antiviral antibody response and induce vaccine-like effects.

Authors:  Dhuha H Nawab
Journal:  Hum Vaccin Immunother       Date:  2021-11-29       Impact factor: 3.452

2.  SGLT2 inhibitor activates the STING/IRF3/IFN-β pathway and induces immune infiltration in osteosarcoma.

Authors:  Wei Wu; Zhenhao Zhang; Doudou Jing; Xin Huang; Dianyun Ren; Zengwu Shao; Zhicai Zhang
Journal:  Cell Death Dis       Date:  2022-06-03       Impact factor: 9.685

3.  Enhanced liver gene transfer and evasion of preexisting humoral immunity with exosome-enveloped AAV vectors.

Authors:  Amine Meliani; Florence Boisgerault; Zachary Fitzpatrick; Solenne Marmier; Christian Leborgne; Fanny Collaud; Marcelo Simon Sola; Severine Charles; Giuseppe Ronzitti; Alban Vignaud; Laetitia van Wittenberghe; Beatrice Marolleau; Fabienne Jouen; Sisareuth Tan; Olivier Boyer; Olivier Christophe; Alain R Brisson; Casey A Maguire; Federico Mingozzi
Journal:  Blood Adv       Date:  2017-10-16

4.  Antibody-antigen kinetics constrain intracellular humoral immunity.

Authors:  Maria Bottermann; Heidrun Elisabeth Lode; Ruth E Watkinson; Stian Foss; Inger Sandlie; Jan Terje Andersen; Leo C James
Journal:  Sci Rep       Date:  2016-11-24       Impact factor: 4.379

5.  Intracellular antibody signalling is regulated by phosphorylation of the Fc receptor TRIM21.

Authors:  Claire Dickson; Adam J Fletcher; Marina Vaysburd; Ji-Chun Yang; Donna L Mallery; Jingwei Zeng; Christopher M Johnson; Stephen H McLaughlin; Mark Skehel; Sarah Maslen; James Cruickshank; Nicolas Huguenin-Dezot; Jason W Chin; David Neuhaus; Leo C James
Journal:  Elife       Date:  2018-04-18       Impact factor: 8.140

6.  A human endothelial cell-based recycling assay for screening of FcRn targeted molecules.

Authors:  Algirdas Grevys; Jeannette Nilsen; Kine M K Sand; Muluneh B Daba; Inger Øynebråten; Malin Bern; Martin B McAdam; Stian Foss; Tilman Schlothauer; Terje E Michaelsen; Gregory J Christianson; Derry C Roopenian; Richard S Blumberg; Inger Sandlie; Jan Terje Andersen
Journal:  Nat Commun       Date:  2018-02-12       Impact factor: 14.919

Review 7.  The TRIMendous Role of TRIMs in Virus-Host Interactions.

Authors:  Sarah van Tol; Adam Hage; Maria Isabel Giraldo; Preeti Bharaj; Ricardo Rajsbaum
Journal:  Vaccines (Basel)       Date:  2017-08-22

8.  Complement C4 Prevents Viral Infection through Capsid Inactivation.

Authors:  Maria Bottermann; Stian Foss; Sarah L Caddy; Dean Clift; Laurens M van Tienen; Marina Vaysburd; James Cruickshank; Kevin O'Connell; Jessica Clark; Keith Mayes; Katie Higginson; Heidrun E Lode; Martin B McAdam; Inger Sandlie; Jan Terje Andersen; Leo C James
Journal:  Cell Host Microbe       Date:  2019-03-26       Impact factor: 21.023

Review 9.  TRIM21-From Intracellular Immunity to Therapy.

Authors:  Stian Foss; Maria Bottermann; Alexandra Jonsson; Inger Sandlie; Leo C James; Jan Terje Andersen
Journal:  Front Immunol       Date:  2019-08-28       Impact factor: 7.561

10.  TRIM21 mediates antibody inhibition of adenovirus-based gene delivery and vaccination.

Authors:  Maria Bottermann; Stian Foss; Laurens M van Tienen; Marina Vaysburd; James Cruickshank; Kevin O'Connell; Jessica Clark; Keith Mayes; Katie Higginson; Jack C Hirst; Martin B McAdam; Greg Slodkowicz; Edward Hutchinson; Patrycja Kozik; Jan Terje Andersen; Leo C James
Journal:  Proc Natl Acad Sci U S A       Date:  2018-09-12       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.